Hasty Briefsbeta

Bilingual

Targeting DYRK1A with Harmine Abrogates the FOXO1-NF-κB Axis to Alleviate Cellular Senescence and Renal Fibrosis - PubMed

4 hours ago
  • #DYRK1A
  • #Cellular Senescence
  • #Renal Fibrosis
  • Harmine, a DYRK1A inhibitor, mitigates renal fibrosis by alleviating tubular epithelial cell senescence.
  • DYRK1A promotes FOXO1 phosphorylation, disrupting mitochondrial fatty acid β-oxidation and leading to cellular senescence.
  • Hypoxia induces lipid accumulation and senescence in HK-2 cells, while Harmine reverses these effects in UUO mice.
  • Clinical data show DYRK1A/FOXO1 expression correlates with fibrosis severity and lipid accumulation in CKD patients.
  • The study identifies the DYRK1A-FOXO1-NF-κB axis as a key regulatory network in renal fibrosis.